Dolutegravir and lamivudine and Oxymorphone Extended-Release Tablets
Determining the interaction of Dolutegravir and lamivudine and Oxymorphone Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dolutegravir / lamivudine
Brand name: Dovato
Synonyms: Dolutegravir and Lamivudine
Generic Name: oxymorphone
Brand name: Opana, Opana ER, Numorphan HCl
Synonyms: Oxymorphone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dolutegravir and lamivudine-Oxymorphone Hydrochloride
- Dolutegravir and lamivudine-Oxymorphone Injection
- Dolutegravir and lamivudine-Oxymorphone Tablets
- Dolutegravir and lamivudine-Oxytocin
- Dolutegravir and lamivudine-Oxytocin Intravenous, Intramuscular
- Dolutegravir and lamivudine-Oxytrol
- Oxymorphone Extended-Release Tablets-Dolutegravir and rilpivirine
- Oxymorphone Extended-Release Tablets-Dolutegravir Sodium
- Oxymorphone Extended-Release Tablets-Dolutegravir Sodium And Lamivudine
- Oxymorphone Extended-Release Tablets-Dolutegravir Sodium and Rilpivirine Hydrochloride
- Oxymorphone Extended-Release Tablets-Dom-Etoposide
- Oxymorphone Extended-Release Tablets-Donatuss DC Syrup